Leading the Way in Life Science Technologies

GEN Exclusives

More »

Jan. 1, Vol. 29, No. 1

    • Point of View

      • Exploring the Human Proteome in Depth
      • Elizabeth Lipp
      • Screening technologies for proteins are still gaining momentum, and as the discipline matures scientists are wondering what technologies are best suited for proteomic profiling. “There’s also a lot of discussion about quantification methodology—what ... more »
      • Linking Disease to Gene Variations
      • Vicki Glaser
      • New technologies and strategies for genetic testing and genomic analysis were the focus of several presentations at the recent American Society of Human Genetics (ASHG) meeting in Philadelphia. Understanding the molecular basis of disease, discernin ... more »
      • Peptide Capacity Holding Steady For Now
      • Vicki Glaser
      • Industry sources project a continuing 10 to 15% growth in the market for biotherapeutic peptide new chemical entities, and more modest growth of slightly greater than 10% for generic peptides. These projections, however, predate the current global e ... more »
      • Stem Cells Continue March Toward Clinic
      • Nina Flanagan
      • Stem cell therapy holds great promise for various diseases. In fact, in what many are hailing as a medical milestone, European researchers have successfully transplanted a trachea built from a patient’s own stem cells to replace a failing airway dam ... more »
    • Wall Street BioBeat

    • The Year of Darwin

      • Celebrating Charles Darwin in 2009
      • John Sterling
      • This year marks the 200th birthday of Charles Darwin (February 12, 1809) and the 150th anniversary of the publication of the Origin of Species . Universities, academic centers, and other scientific organizations all over the globe have a plethora of ... more »
    • Tutorials

      • Impact of Ultrafiltration of Hydrolysates
      • Tobi Limke
      • Hydrolysates (peptones) are widely used in biopharmaceutical manufacturing to enhance cellular growth and production. Ultrafiltration is often utilized to remove large molecular weight entities including endotoxin from hydrolysates. While minimizati ... more »
      • Tritiated Opiate Receptor Radioligands
      • Crist Filer
      • The alleviation of pain is perhaps the greatest long-standing goal of both ancient and modern medicine. Quite recently, opiate receptors were implicated in the propagation of pain. With exquisite complimentary molecular architecture, these protein p ... more »
    • Corporate Profile

      • Sequella Takes On Pernicious Enemies
      • Ilene Schneider
      • Today, about one-third of the world’s population, or two billion people, carry the tuberculosis (TB) bacteria, although most never develop active TB disease. Studies estimate that 65 to 70 million people have active TB, there are 8 to 10 million new ... more »
    • BioMarket Trends

      • Technology Showcase for New Screening Software
      • A number of HCS vendors will be launching software packages to go along with their instrument portfolios at “High Content Screening’s” Technology Showcase. According to Mark Collins, marketing manager for cellular imaging at Thermo Fisher Scientific ... more »

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »